טוען...
Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
BACKGROUND: Acute respiratory distress syndrome (ARDS) in humans is caused by an unchecked proinflammatory response that results in diffuse and severe lung injury, and it is associated with a mortality rate of 35 to 45%. Mesenchymal stromal cells (MSCs; ‘adult stem cells’) could represent a promisin...
שמור ב:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2014
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046388/ https://ncbi.nlm.nih.gov/pubmed/24887266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-3-48 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|